Public Health Crisis: Unqualified Individuals & Risks
- New recommendations regarding COVID-19 vaccines from the Department of Health and Human Services (HHS) are drawing criticism.
- The controversy stems from the backgrounds of those involved in shaping the new policy.
- In May, FDA Commissioner Marty Makary and Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, outlined a "new COVID-19 ideology" in The New england...
HHSS new COVID-19 vaccine guidelines are under fire, as experts scrutinize the qualifications of those behind the policy shifts. The announcement limits access, sparking worries the changes will discourage vaccination. central to the controversy are concerns that key decision-makers lack adequate expertise in infectious diseases and related fields, sidelining established scientific advisory bodies. Pregnant women and children face new stipulations, further fueling the debate, while critics highlight the focus on the rare side effect of myocarditis. This situation, described as a ”hijacking of public health” by unqualified individuals, raises a crucial question for News Directory 3 readers: What does this mean for public health? Discover what’s next as experts call for a return to fact-based processes.
COVID Vaccine Policy Sparks Concern Among Public Health Experts
Updated June 01, 2025
New recommendations regarding COVID-19 vaccines from the Department of Health and Human Services (HHS) are drawing criticism. The updated guidelines limit access to the shots, raising concerns among public health experts about the decision-making process.
The controversy stems from the backgrounds of those involved in shaping the new policy. Critics point to a perceived lack of relevant expertise in infectious diseases, virology, immunology, and vaccinology among key individuals.

In May, FDA Commissioner Marty Makary and Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, outlined a “new COVID-19 ideology” in The New england Journal of Medicine. Shortly after, Makary, HHS Secretary Robert F. Kennedy Jr., and NIH Director Jay Bhattacharya announced plans to remove pregnant women and children from the CDC’s recommended immunization schedule.
Critics argue that established scientific advisory bodies, such as the CDC’s Advisory Committee on immunization Practices (ACIP), were bypassed in the process.
The new guidance on pregnant women and children is particularly contentious. While the CDC maintains that vaccination ameliorates risks associated with COVID-19 during pregnancy, the HHS now advises against it for healthy pregnant women. Concerns also exist regarding how “healthy” will be defined for vaccination eligibility and the potential barriers to access for vulnerable populations.
This is public health policy making by fiat, by individuals with no relevant expertise in infectious diseases, virology, immunology, or vaccinology… ACIP, the CDC, and any other outside scientific and clinical advisers were all sidelined.
Moreover, the HHS’s emphasis on myocarditis as a common vaccine side affect is disputed. Experts say it is rare and typically mild,suggesting the focus aims to discourage COVID-19 vaccination.
Gregg Gonsalves, a public health expert, describes the situation as a “hijacking of public health decision-making by unqualified ideologues,” warning of potential future consequences.
What’s next
The long-term effects of these policy changes remain to be seen, but public health experts are urging a return to clear, evidence-based decision-making processes involving qualified professionals.
